Results 81 to 90 of about 51,719 (196)

Molecular epidemiology and β-lactam resistance mechanisms of Enterobacter cloacae complex isolates obtained from bloodstream infections, Kyoto, Japan

open access: yesMicrobiology Spectrum
The Enterobacter cloacae complex (ECC) comprises multiple species that require genomic analysis for precise identification. They produce inducible AmpC β-lactamase and may carry acquired β-lactamases, which are responsible for cefotaxime and cefepime ...
Akihiko Matsuo   +5 more
doaj   +1 more source

The bactericidal activity of levofloxacin compared with ofloxacin, D-ofloxacin, ciprofloxacin, sparfloxacin and cefotaxime against Streptococcus pneumoniae. [PDF]

open access: yes, 1997
The bactericidal activity of levofloxacin was compared with that of four other quinolones and one cephalosporin against four strains of Streptococcus pneumoniae with varying degrees of penicillin G susceptibility.
George, J., Morrissey, Ian
core  

Physicochemical Stability of Cefotaxime Sodium in Polypropylene Syringes at High Concentrations for Intensive Care Units

open access: yes, 2019
Cefotaxime sodium is an antibiotic used to treat severe infections such as in intensive care units (ICUs). The recommended dose of cefotaxime sodium can vary from 3 grams (g) to 24 g per day and publications have demonstrated that continuous ...
D’Huart Elise   +4 more
core   +1 more source

Hospital in the Home in NSW, CHERE Project Report No 16 [PDF]

open access: yes
Hospital in the home ...
Marion Haas   +2 more
core  

Toxicology of cefotaxime in comparison to other cephalosporins

open access: yes, 1980
Cefotaxime is very well tolerated in animals, the LDJ0 in rats and mice following intravenous administration is in the range of 9 to 10 g/kfr This>s unusual for a chemotherapeutic agent Even the LD50 of penicillin G in the mouse is in the range of 2 g/
T. Sakagochi   +4 more
core  

Antibacterial activity of cefotaxime

open access: yes, 1980
Cefotaxime (CTAX), a new cephalosporin derivative, has a broad antibacterial spect-rum and is stable to /Mactamases produced by various species of bacteria.
S. Masuyoshi, M. Inoue, S. Mitsuhashi
core  

Cefotaxime in the treatment and prophylaxis of surgical infections

open access: yes, 1997
Cefotaxime has retained its broad-spectrum activity against the key pathogens in surgical infection, despite 15 years of widespread use. It has good activity against a wide range of Gram-positive and Gram-negative aerobes and most anaerobes, except ...
Jones RN   +3 more
core  

PERBANDINGAN ANTARA PAPARAN CIPROFLOXACIN DAN CEFOTAXIME TERHADAP TIMBULNYA ESCHERICHIA COLI ESBL [PDF]

open access: yes, 2017
To compare ciprofloxacin and cefotaxime exposure to develop ESBL producing Escherichia coli (E.coli). Methods: A total of 16 isolates of cefotaxime sensitive E.coli and ciprofloxacin were exposed to ciprofloxacin and cefotaxime for 14 days using the ...
MUHAMMAD AMIN, NIM011328226303
core  

Consultancy to progress hospital in the home care provision: Final report, CHERE Project Report No 13 [PDF]

open access: yes
In July 1998, the Commonwealth Department of Health and Family Services commissioned the Centre for Health Economics Research and Evaluation (CHERE) to identify and document Hospital in the Home (HITH) care models nationally and internationally.
Marion Haas   +3 more
core  

Treatment of severe neonatal infections with cefotaxime. Efficacy and pharmacokinetics

open access: yes, 1982
We studied the pharamcokinetics and efficacy of cefotaxime in 32 neonates with severe gram-negative infections. Many of these patients had been treated unsuccessfully with combinations of antibiotics.
Dellagrammaticas, H.   +6 more
core   +1 more source

Home - About - Disclaimer - Privacy